Fluor Corp Stock Price, News & Analysis

Fluor Corporation (NYSE: FLR) announced the opening of the Medford Branch of the Green Line Extension light rail project in Massachusetts. Developed by the Green Line Extension Constructors joint venture, this project enhances transportation access in the Boston area. The 4-mile line expects a daily ridership of 45,000 by 2030. This line follows the first branch opened in March 2022 and aims to support regional mobility and reduce car traffic and emissions. The project is part of Massachusetts Bay Transportation Authority initiatives for sustainable urban growth.

Fluor Corporation (NYSE: FLR) has successfully completed the $666 million Southern Gateway project in Dallas, enhancing the Interstate 35-E (I-35E) corridor. This project, initiated by the Texas Department of Transportation in 2017, included the reconstruction and widening of 10 miles of highway, aimed at alleviating congestion and improving safety. The opening of the new road was celebrated by state and local leaders, affirming Fluor's commitment to regional infrastructure development.

Fluor Corporation (NYSE: FLR) and the Texas Department of Transportation recently broke ground on the I-35 Capital Express South project in Austin, Texas. Awarded in Q2 2022, the project aims to alleviate traffic congestion along I-35, which sees over 150,000 vehicles daily. Thomas Nilsson, president of Fluor’s Infrastructure business, highlighted the project’s role in enhancing mobility and supporting Texas's economic growth. Substantial completion is expected by early 2028.

Fluor Corporation (NYSE: FLR) has announced substantial engineering completion for Albemarle's Lithium Conversion project in Meishan City, Sichuan Province, China. This facility aims to produce 50,000 tons of lithium hydroxide per year, crucial for electric vehicle batteries. The project has reported over 3 million safe hours worked, showcasing significant safety milestones. Fluor continues to provide engineering, procurement, and construction management services, positioning Albemarle as a key player in the growing lithium market.

Fluor Corporation (NYSE: FLR) announced its participation in two investor conferences this year. On November 10, 2022, CFO Joe Brennan and IR head Jason Landkamer will attend the Baird Global Industrial Conference. Following this, they will join the Credit Suisse 10th Annual Industrials Conference on December 1, 2022, featuring a fireside chat at 8:45 a.m. ET. A live webcast and replay will be available at investor.fluor.com. Fluor, based in Irving, Texas, generated $12.4 billion in revenue in 2021.

Fluor Corporation (NYSE: FLR) has secured a contract for engineering and procurement services to develop a major renewable diesel complex at the Strathcona refinery in Alberta, Canada. This facility is projected to be the largest renewable diesel production site in Canada, producing 20,000 barrels daily from local feedstocks. The contract value was included in Fluor's third quarter 2022 bookings. Fluor's involvement aims to support sustainable energy initiatives, integrating their expertise with local resources.

Fluor Corporation (NYSE: FLR) has secured two engineering, procurement, and construction management contracts from BASF, valued at over $2 billion. These contracts are part of BASF's new Verbund program in Zhanjiang, Guangdong, China, and are expected to enhance Fluor's longstanding client relationship. The project scope includes the ethylene oxide/ethylene glycol unit and infrastructure utilities, supported by Fluor's Shanghai office. This contract adds to Fluor's significant history of projects with BASF over the past two decades.

Fluor Corporation (NYSE: FLR) has secured a 4-year extension for its management and operating contract at the Savannah River Site from the U.S. Department of Energy (DOE), with an optional additional year. The total reimbursable contract value is $12 billion for 5 years, with Fluor booking $4.5 billion in Q3 for its 4-year share. The Savannah River Site focuses on environmental management and nuclear non-proliferation efforts, ensuring continuous operations and supporting U.S. security.

Fluor Corporation (NYSE: FLR) has been selected by a leading biologics company to manage procurement and construction for a large-scale biologics drug substance manufacturing facility in Scandinavia. The contract, valued in the multi-hundred-million-dollar range, is expected to be booked in Q3 2022. This facility will enhance production capacity for advanced biologics, including vaccines and oncology medicines, with operations slated to begin in 2025. Fluor's Advanced Technologies & Life Sciences division, supported by the Nordic Technology Hub in Copenhagen, is leading the project.